Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells. Prangsaengtong O*, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K. Vasc Med. 2018 Jun;23(3):201-211.

01 Jun 2018
0

Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.

Prangsaengtong O*, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K.

Vasc Med. 2018 Jun;23(3):201-211.

Tags

Share this

Related Posts

Andrographis paniculata dissolution investigation and pharmacokinetic studies of four major active diterpeniods after multiple oral dose. Pholphana N, Panomvana D, Rangkadilok N, Suriyo T, Puranajoti P, Ungtrakul T, Pongpun W, Thaeopattha S, Songvut P, Satayavivad J. J Ethnopharmacol 2016; 194: 513-21.

Recent Posts